Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease liver cirrhosis
Phenotype |portal hypertension
Sentences 75
PubMedID- 24697006 In second pregnancy, medically induced abortion was performed in the 12th week because of deterioration of the underlying disease, liver cirrhosis with portal hypertension.
PubMedID- 25374728 Variceal bleeding is the major complication of portal hypertension in patients with liver cirrhosis.
PubMedID- 20652243 Four patients underwent splenectomy because of liver cirrhosis with portal hypertension and gastroesophageal variceal bleeding.
PubMedID- 24974920 Evaluation of cardiac systolic and diastolic functions in liver cirrhosis patients with portal hypertension conventional was done by conventional doppler echocardiography and tdi.
PubMedID- 24757655 Background/aims: this retrospective study assessed the clinical outcome of a transjugular intrahepatic portosystemic shunt (tips) procedure for managing portal hypertension in koreans with liver cirrhosis.
PubMedID- 21701671 She was a known case of cryptogenic liver cirrhosis with portal hypertension.
PubMedID- 21506350 An analysis of 115 liver cirrhosis patients with portal hypertension was made to find out which of them had variceal bleeding and high risk of its development.
PubMedID- 26516439 The american association for the study of liver diseases (aasld) and the european association for the study of the liver (easl) have established guidelines that indicate that liver cirrhosis with portal hypertension is a relative contraindication for hepatic resection because of the high risk liver failure after the operation (14–17).
PubMedID- 21802316 Purpose: to develop a clinically relevant porcine model of liver cirrhosis with portal hypertension by means of hepatic transarterial embolization.
PubMedID- 22957328 Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis.
PubMedID- 25933224 liver cirrhosis with portal hypertension is characterized by systemic and splanchnic vasodilatory substances release, especially nitric oxide (no) and prostacyclin [3], which lead to hyperdynamic circulatory status, and further increased mesenteric blood flow and portal inflow.
PubMedID- 23909264 Results: hepatic vein catheterisation is reliable for assessing the portal hypertension in the group of patients with liver cirrhosis of ethylic etiology.
PubMedID- 22900219 The patient underwent a computed tomography (ct) of the abdomen which showed liver cirrhosis with signs of portal hypertension, a tortuous and ectasic splenic artery with some widely dilated sections (max 24 mm caliber), and massive aneurysmal dilation in the middle tract (90 mm of maximum diameter) with partly calcified walls, inducing a cranial displacement of the tail and the body of the pancreas (figure 1).
PubMedID- 24563796 Relevant diagnoses of the patient were (i) known hypertensive cardiac disease (transthoracic echocardiography 6 months before had shown a lv-ef of 54% and a light mitral and tricuspid insufficiency) and (ii) liver cirrhosis with portal hypertension.
PubMedID- 24729881 17 (7%) patients had a mild hepatic comorbidity (score 1) (bilirubin > uln to 1.5 × uln or ast/alt > uln to 2.5 × uln) and 1 patient additional liver cirrhosis with portal hypertension (score 3).
PubMedID- 21705304 A detailed interview and examination by occupational health and other medical specialists revealed that the patient had been suffering from wilson's disease from the age of 13, and had now developed hepatic manifestations (compensated liver cirrhosis with portal hypertension), neurological manifestations (dystonia, dysarthria, muscle weakness, vertigo), and psychiatric manifestations (depression, insomnia, cognitive impairment) of the disease, including problems partially caused by long-lasting treatment with copper chelating agents (neurological and haematological manifestations).
PubMedID- 23984413 Spleen stiffness, but not liver stiffness, was positively correlated with the presence of ascites as a representative marker of portal hypertension in patients with liver cirrhosis and the spleen stiffness did not correlate with the presence of esophageal varices in chronic hepatitis c patients.
PubMedID- 21606920 The experimental study of liver cirrhosis with portal hypertension syndrome, modeled in 38 dogs, has been performed.
PubMedID- 23855493 Impaired endothelial function is a major cause of portal hypertension in liver cirrhosis.
PubMedID- 26412302 Additionally, neo-angiogenesis has been identified as a key mechanism in the progression of liver cirrhosis with portal hypertension3.
PubMedID- 25798930 Objective: to investigate the role of contrast-enhanced ultrasonography (ceus) and doppler ultrasonography (dus) in the diagnosis of severe portal hypertension (ph) in patients with liver cirrhosis (lc).
PubMedID- 24400086 The hemodynamic alteration of portal hypertension in patients with liver cirrhosis contributes to most of the clinical manifestations of the disease: gastrointestinal bleeding, hepatic encephalopathy, ascites and renal failure.
PubMedID- 25656015 [case report : bleeding from ileal conduit in a patient with portal hypertension due to liver cirrhosis type c].
PubMedID- 26091449 Esophageal varix is one of the serious complications of liver cirrhosis resulting from portal hypertension.1 given the high prevalence of varices and the significant mortality rate associated with variceal hemorrhage, early diagnosis of clinically significant portal hypertension (≥10 mm hg) and varices is of paramount importance in the management of compensated cirrhosis and in the prevention of liver-related morbidity and mortality.
PubMedID- 23743385 However, an increase in splenic blood flow may play a role in the development of saa in patients with portal hypertension due to liver cirrhosis or transplantation.

Page: 1 2